Skip to main content
. 2011 Mar 18;45(4):851–857. doi: 10.1165/rcmb.2010-0455OC

Figure 3.

Figure 3.

BLT1 antagonist reduces AHR and airway inflammation 6 hours after secondary challenge. (A) RL was measured in sensitized and challenged mice 6 hours after the secondary provocation with OVA. n = 12 in each group. *P < 0.05 compared with all other groups. (B) Cellular composition in bronchoalveolar lavage (BAL) fluid. (C) BAL cytokine levels. (D) BAL chemokine levels. (E) BAL IL-17 levels. *P < 0.05 compared with OVA/OVA/vehicle.